info@trade-jp.net
menu
News / Blog
Delivery and Holidays in September
02/09/2024
Dear Customers!
REGARDING DELIVERY, we can ship to almost any country as per 01.09.2024.
Catalog
| Product Code |
|
| Availability | 5 |
| Price | USD 880.00 |
| Qty |
Evrenzo tablets 100 mg for renal anemia (roxadustat)
Product Code :
Availability : 5
USD 880.00
Are Evrenzo tablets 100 mg effective for the treatment of renal anemia (roxadustat)?
Renal anemia treatment is essential for those suffering from chronic kidney disease, and Evrenzo tablets provide an effective solution. Containing roxadustat, a HIF prolyl-hydroxylase inhibitor, these renal anemia tablets activate hypoxia inducible factor (HIF) pathways. By inhibiting HIF prolyl hydroxylase (HIF-PH), Evrenzo prevents the degradation of HIF, boosting the production of erythropoietin. This critical hormone promotes the production of red blood cells, improving anemia related to renal diseases.
Why Choose Evrenzo Tablets for Renal Anemia Treatment?
Evrenzo tablets are designed to tackle the underlying causes of renal anemia. The HIF pathway activation and erythropoietin stimulation result in increased red blood cell production, addressing the deficiency caused by kidney disease. This mechanism makes Evrenzo an innovative and reliable option for patients needing renal anemia treatment.
Scientific Evidence Supporting Evrenzo's Efficacy
The effectiveness of roxadustat tablets in treating renal anemia is supported by extensive scientific research. One notable study, "Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis," demonstrated the substantial benefits of this medication. During the 18-week open-label period, researchers observed an average increase in hemoglobin levels of 1.9±1.2 g per deciliter. Additionally, the mean reduction in hepcidin levels was 56.14±63.40 ng, indicating enhanced iron availability, and a significant reduction in total cholesterol levels of 40.6 mg per deciliter was also noted. These findings confirm that Evrenzo tablets are a potent and reliable choice for renal anemia treatment.
- Improved Hemoglobin Levels: Evrenzo tablets help maintain and increase hemoglobin levels, ensuring better oxygen transport throughout the body.
- Enhanced Iron Availability: By reducing hepcidin levels, these tablets ensure more iron is available for red blood cell production.
- Lower Cholesterol Levels: The reduction in cholesterol levels adds an additional health benefit, particularly for those with renal anemia.
- Convenient Dosage: As an oral medication, Evrenzo offers a convenient and non-invasive option for patients, improving adherence to treatment regimens.
For those seeking an effective solution for renal anemia, Evrenzo tablets provide a scientifically backed option that addresses the root causes of the condition. By increasing red blood cell production and improving overall iron availability, roxadustat tablets offer a comprehensive approach to managing renal anemia. Trust Evrenzo for a proven and convenient treatment that delivers measurable results.
Package details: 30 tablets
Dosage and administration:
For patients untreated by erythropoiesis stimulating agent: adults should start taking this medicine with 50 mg of the active ingredient at a time, 3 times a week. Thereafter, your doctor may adjust the dosage according to the condition of the patient. The maximum single dose is 3.0 mg/kg.
For patients switching from erythropoiesis stimulating agent: adults should start taking this medicine with either 70 mg or 100 mg of the active ingredient at a time, 3 times a week. Thereafter, your doctor may adjust the dosage according to the condition of the patient. The maximum single dose is 3.0 mg/kg.
This medicine contains 100 mg of the active ingredient in one tablet.
Take this medicine 3 times a week, at intervals of 2 to 3 days (e.g. on Monday, Wednesday and Friday or on Tuesday, Thursday and Saturday).
Anemia test (measuring hemoglobin concentration) should be performed before using this medicine. To measure serum concentrations of hemoglobin, blood tests should be periodically performed while using this medicine.
Active components: roxadustat
Therapeutic effect: treatment of renal anemia
Contraindications and precautions: Do not use for patients with hypertension, malignant tumor, proliferative diabetic retinopathy, macular edema, exudative age-related macular degeneration, retinal vein occlusion or liver dysfunction. Do not use for patients with cerebral infarction, myocardial infarction or pulmonary embolism or a history of those. Do not use for pregnant or breastfeeding women. Female patients should use adequate contraception while taking this medicine and for a certain period of time after the last dose of this medicine. Breastfeeding should be avoided from the start to 28 days after the last dose of this medicine.
Hypertension may occur when using this medicine. Since central hypothyroidism may occur, thyroid function tests should be periodically performed while using this medicine. Patient needs to take iron to get an adequate efficacy.
If allergic or any other unusual symptoms occur, discontinue use and consult with your doctor.
There are no reviews for this product.
Write a review
Rating
Bad
Good
Related Products
News
Delivery and Holidays in September
02/09/2024
Dear Customers!
REGARDING DELIVERY, we can ship to almost any country as per 01.09.2024.
WE SHIP to USA, Canada, UK, all EU countries, UAE, Australia, New Zealand, Canada, Hong-Kong, Israel, Brazil, India, China, Taiwan, Korea, Vietnam, Mexico, Ukraine and almost all other countries!
IF JAPAN POST DOES NOT SHIP OR SHIPS BY SURFACE MAIL ONLY - WE SHALL SHIP BY COURIER
PLEASE CHECK DELIVERY PAGE - WE CAN SHIP TO ANY COUNTRY
Check tracking number and feedback on our Guarantees page:
https://bio-japan.net/customers-voice
PAY ATTENTION!
SEPTEMBER 16th (Monday)
SEPTEMBER 23rd (MONDAY)
an official holiday in Japan! There will be THREE-DAYS' HOLIDAYS TWO TIMES!!!
Delays in shiping are possible for orders orderes before or dugring this date.
Sincerely yours
Japan Health Centre